Transplanted hearts take on the biological age of their new human owners, according to a preprint study published on bioRxiv by Harvard Medical School molecular biologist Jesse Poganik and his research team. Older hearts placed into younger recipients show signs of biological rejuvenation, while younger organs in older bodies exhibit accelerated aging.
Molecular Biologists Track Epigenetic Clocks in Mice and Humans
Chronological age differs from biological age, which tracks accumulated molecular and physiological changes over time. To measure this, researchers utilize epigenetic clocks that analyze chemical tags known as methyl groups attached to DNA. Poganik and colleagues investigated whether these biological markers shift when an organ enters a significantly older or younger body.
The team initially performed heterotopic heart transplants in mice. In this experimental setup, recipient animals retained their original hearts while a donor organ connected to blood vessels in the neck. Four to six months later, DNA methylation analysis revealed that transplanted hearts assimilated the biological age of their new host ecosystem. Intriguingly, this effect operated in a single direction: the recipients’ original hearts, livers, and blood remained unaffected by the age of the donor tissue.
Human Biopsy Samples Confirm Mouse Transplant Findings
Human tissue analysis yielded parallel results. Researchers examined archived heart tissue collected from 11 transplant recipients during follow-up care. Patient ages varied substantially from their donors, spanning differences from recipients 24 years younger to 50 years older than the source.
DNA methylation analysis of these human biopsies demonstrated that the biological ages of the transplanted hearts aligned more closely with the recipients than the original donors. Follow-up records from hundreds of heart recipients, covering one year post-transplantation, showed that physical performance metrics such as functional capacity and maximum oxygen consumption declined with increasing recipient age regardless of donor age.
Transplant Programs Could Expand Donor Age Limits
Current medical guidelines generally favor heart donors under 45 years of age, and few transplant programs routinely accept organs from donors older than 50. However, the discovery that older hearts lose biological hallmarks of aging inside younger bodies suggests chronological age alone does not dictate an organ’s functional potential. The findings could eventually allow older donor hearts to be considered for younger recipients, expanding a severely limited pool of available organs.
Uncertainties remain regarding whether biological rejuvenation translates into better long-term patient survival outcomes. The exact timeline of the transformation in humans, its duration, and its potential presence in other transplanted organs also require further investigation. Gene activity analysis in mice pointed toward mitochondrial and metabolic processes as potential drivers of this age exchange.
“Our carefully controlled mouse study paired with our extensively quality-controlled human DNAm data present compelling evidence supporting age assimilation of tissues placed into heterochronic systemic environments,” the researchers wrote on bioRxiv.
Transplant Age Assimilation Questions
How do scientists measure biological age in transplanted organs?
Researchers use epigenetic clocks to detect specific patterns of chemical tags called methyl groups attached to DNA within the tissue samples.
What patient age gaps were examined in the human tissue analysis?
The study analyzed archived heart tissue from 11 transplant recipients whose ages ranged from 24 years younger than their donors to 50 years older.
Do donor hearts affect the biological age of the recipient’s original organs?
No, the biological ages of the recipients’ original hearts, livers, and blood remain mostly unaffected by whether the transplanted heart came from an older or younger donor.
What recommended donor age limit might this research influence?
Current guidelines recommend donors under 45, but demonstrating that older hearts rejuvenate in younger bodies could expand organ acceptance beyond current limits.
Related reading